PDL1 expression in inflammatory breast cancer is frequent and predicts for the pathological response to chemotherapy

We retrospectively analyzed PDL1 mRNA expression in 306 breast cancer samples, including 112 samples of an aggressive form, inflammatory breast cancer (IBC). PDL1 expression was heterogeneous, but was higher in IBC than in non-IBC. Compared to normal breast samples, PDL1 was overexpressed in 38% of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Autores principales: Bertucci, François, Finetti, Pascal, Colpaert, Cécile, Mamessier, Emilie, Parizel, Maxime, Dirix, Luc, Viens, Patrice, Birnbaum, Daniel, van Laere, Steven
Formato: Artigo
Lenguaje:Inglês
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4537030/
https://ncbi.nlm.nih.gov/pubmed/25940795
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares